A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency
IRF4
DOI:
10.1126/sciimmunol.ade7953
Publication Date:
2023-01-20T13:58:33Z
AUTHORS (103)
ABSTRACT
Interferon regulatory factor 4 (IRF4) is a transcription (TF) and key regulator of immune cell development function. We report recurrent heterozygous mutation in IRF4, p.T95R, causing an autosomal dominant combined immunodeficiency (CID) seven patients from six unrelated families. The exhibited profound susceptibility to opportunistic infections, notably Pneumocystis jirovecii , presented with agammaglobulinemia. Patients’ B cells showed impaired maturation, decreased immunoglobulin isotype switching, defective plasma differentiation, whereas their T contained reduced H 17 FH populations cytokine production. A knock-in mouse model T95R severe defect antibody production both at the steady state after immunization different types antigens, consistent CID observed these patients. IRF4 variant maps TF’s DNA binding domain, alters its canonical specificities, results simultaneous multimorphic combination loss, gain, new functions for IRF4. behaved as gain-of-function hypermorph by higher affinity than WT . Despite this increased DNA, transcriptional activity on genes was reduced, showcasing hypomorphic Simultaneously, neomorph noncanonical sites alter gene expression profile, including exclusively induced but not This previously undescribed pathophysiology disrupts normal lymphocyte biology, human disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (77)
CITATIONS (20)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....